Back to Search
DR. DAVID W. DEATON M.D.
M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1265450019IndividualAccepts Medicare
Specialties, Licenses & Credentials
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
72851(MA)
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
PMID 19288889·J Health Life Sci Law·2009
8-other
The phase I multicenter trial (STAPLE-1) of the Aptus endovascular repair system: results at 6 months and 1 year.
PMID 19341879·J Vasc Surg·2009
3-trial
FXR agonist activity of conformationally constrained analogs of GW 4064.
PMID 19586769·Bioorg Med Chem Lett·2009
7-preclinical
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064.
PMID 19410460·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.
PMID 18818070·Bioorg Med Chem Lett·2008
8-other
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.
PMID 18078750·Bioorg Med Chem Lett·2008
7-preclinical
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.
PMID 18243695·Bioorg Med Chem Lett·2008
8-other
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.
PMID 18621523·Bioorg Med Chem Lett·2008
7-preclinical
Design optimization of a novel pMDI actuator for systemic drug delivery.
PMID 18158718·J Aerosol Med·2007
8-other
Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing heterobiaryl carboxylic acids.
PMID 17560786·Bioorg Med Chem Lett·2007
8-other
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors.
PMID 17157021·Bioorg Med Chem Lett·2007
8-other
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
PMID 16376075·Bioorg Med Chem Lett·2006
4-observational
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
PMID 16290936·Bioorg Med Chem Lett·2006
7-preclinical
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonists.
PMID 16640337·J Med Chem·2006
7-preclinical
Novel and potent cyclic cyanamide-based cathepsin K inhibitors.
PMID 15780613·Bioorg Med Chem Lett·2005
7-preclinical
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.
PMID 15982880·Bioorg Med Chem Lett·2005
7-preclinical
Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles.
PMID 15993587·Bioorg Med Chem Lett·2005
8-other
A structural screening approach to ketoamide-based inhibitors of cathepsin K.
PMID 15837295·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 MEDICAL CENTER DR STE 512
SPRINGFIELD, MA 01107 - Phone
- (413) 794-5550
Quick Facts
- NPI
- 1265450019
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile